Shihua Shi

1.0k total citations
36 papers, 629 citations indexed

About

Shihua Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Shihua Shi has authored 36 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Shihua Shi's work include Heme Oxygenase-1 and Carbon Monoxide (12 papers), Inflammasome and immune disorders (7 papers) and High Altitude and Hypoxia (7 papers). Shihua Shi is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (12 papers), Inflammasome and immune disorders (7 papers) and High Altitude and Hypoxia (7 papers). Shihua Shi collaborates with scholars based in China, Switzerland and United States. Shihua Shi's co-authors include Caixia Pei, Demei Huang, Yongcan Wu, Yilan Wang, Zhenxing Wang, Zherui Shen, Fei Wang, Yacong He, Xiaomin Wang and Xiaoming Wang and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Microbiology and Biochemical Pharmacology.

In The Last Decade

Shihua Shi

35 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shihua Shi China	15	349	202	112	81	61	36	629
Zhenxing Wang China	16	412 1.2×	238 1.2×	134 1.2×	98 1.2×	80 1.3×	63	808
Demei Huang China	16	378 1.1×	220 1.1×	121 1.1×	98 1.2×	69 1.1×	37	701
Caixia Pei China	15	366 1.0×	216 1.1×	118 1.1×	98 1.2×	67 1.1×	33	644
Yongcan Wu China	15	362 1.0×	218 1.1×	117 1.0×	98 1.2×	58 1.0×	30	637
Chunxiao Liang China	13	264 0.8×	97 0.5×	79 0.7×	39 0.5×	14 0.2×	28	572
Zherui Shen China	13	251 0.7×	175 0.9×	97 0.9×	56 0.7×	61 1.0×	24	419
Fa Sun China	14	267 0.8×	205 1.0×	73 0.7×	18 0.2×	26 0.4×	49	610
Shakir Idris Saudi Arabia	17	161 0.5×	49 0.2×	52 0.5×	110 1.4×	56 0.9×	36	693
Xu Zhou China	13	296 0.8×	40 0.2×	108 1.0×	57 0.7×	40 0.7×	35	750
Beibei Gao China	16	250 0.7×	55 0.3×	96 0.9×	40 0.5×	23 0.4×	64	737

Countries citing papers authored by Shihua Shi

Since Specialization

Citations

This map shows the geographic impact of Shihua Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shihua Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shihua Shi more than expected).

Fields of papers citing papers by Shihua Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shihua Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shihua Shi. The network helps show where Shihua Shi may publish in the future.

Co-authorship network of co-authors of Shihua Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Shihua Shi. A scholar is included among the top collaborators of Shihua Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shihua Shi. Shihua Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Qian, Demei Huang, Junling Liu, et al.. (2025). The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management. Frontiers in Microbiology. 16. 1705487–1705487.

Pan, Jie, et al.. (2024). Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease. Advanced Science. 12(2). e2412184–e2412184. 2 indexed citations

Liu, Junling, Caixia Pei, Zherui Shen, et al.. (2024). Preconditioning with Ginsenoside Rg3 mitigates cardiac injury induced by high-altitude hypobaric hypoxia exposure in mice by suppressing ferroptosis through inhibition of the RhoA/ROCK signaling pathway. Journal of Ethnopharmacology. 337(Pt 2). 118861–118861. 11 indexed citations

Wang, Yilan, Ying Liu, Caixia Pei, et al.. (2024). Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury. Biomedicine & Pharmacotherapy. 175. 116793–116793. 13 indexed citations

Zhu, Qikui, Jie Pan, Bonan Chen, et al.. (2023). An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine. Frontiers in Pharmacology. 14. 1257345–1257345. 8 indexed citations

Huang, Demei, Zherui Shen, Caixia Pei, et al.. (2023). Sipeimine attenuates PM2.5-induced lung toxicity via suppression of NLRP3 inflammasome-mediated pyroptosis through activation of the PI3K/AKT pathway. Chemico-Biological Interactions. 376. 110448–110448. 14 indexed citations

Huang, Demei, Caixia Pei, Zherui Shen, et al.. (2023). Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathway. Biochemical Pharmacology. 213. 115623–115623. 8 indexed citations

Pei, Caixia, Yilan Wang, Zherui Shen, et al.. (2023). Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway. European Journal of Pharmacology. 959. 176065–176065. 12 indexed citations

Shen, Zherui, Yilan Wang, Caixia Pei, et al.. (2023). Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway. International Immunopharmacology. 121. 110423–110423. 17 indexed citations

10.

Shen, Zherui, Demei Huang, Caixia Pei, et al.. (2023). Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis. Biomedicine & Pharmacotherapy. 167. 115607–115607. 13 indexed citations

11.

Shi, Shihua, Demei Huang, Yongcan Wu, et al.. (2023). Salidroside pretreatment alleviates PM2.5 caused lung injury via inhibition of apoptosis and pyroptosis through regulating NLRP3 Inflammasome. Food and Chemical Toxicology. 177. 113858–113858. 17 indexed citations

12.

Wang, Yilan, Zherui Shen, Demei Huang, et al.. (2022). Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approach. Ecotoxicology and Environmental Safety. 239. 113615–113615. 53 indexed citations

13.

Huang, Demei, Shihua Shi, Yilan Wang, et al.. (2022). Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome‐mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice. Biomedicine & Pharmacotherapy. 150. 112978–112978. 28 indexed citations

14.

Guo, Ming, Shihua Shi, Shenglan Wang, et al.. (2022). Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial. Frontiers in Cardiovascular Medicine. 9. 888724–888724. 1 indexed citations

15.

Shi, Shihua, Fei Wang, Huan Yao, et al.. (2022). Oral Chinese Herbal Medicine on Immune Responses During Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 8. 685734–685734. 17 indexed citations

16.

Wang, Yilan, Zherui Shen, Demei Huang, et al.. (2022). Pretreatment with rosavin attenuates PM2.5‐induced lung injury in rats through antiferroptosis via PI3K/Akt/Nrf2 signaling pathway. Phytotherapy Research. 37(1). 195–210. 30 indexed citations

17.

Wang, Xiaomin, Shuiqin Li, Yongcan Wu, et al.. (2022). Effect of omega-3 fatty acids on TH1/TH2 polarization in individuals with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials. 23(1). 179–179. 1 indexed citations

18.

Wang, Xiaoming, Yilan Wang, Demei Huang, et al.. (2022). Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. International Immunopharmacology. 112. 109186–109186. 106 indexed citations

19.

Pei, Caixia, Fei Wang, Demei Huang, et al.. (2021). Astragaloside IV Protects from PM2.5-Induced Lung Injury by Regulating Autophagy via Inhibition of PI3K/Akt/mTOR Signaling in vivo and in vitro. Journal of Inflammation Research. Volume 14. 4707–4721. 45 indexed citations

20.

Shi, Shihua. (2010). Analysis on the Correlated Factors of Methylene Tetrahydrofolate Reductase C676T Mutation and the Different TCM Syndromes in Early Diabetic Nephropathy. Journal of traditional chinese medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact